StockWatch
·
Pharmaceuticals
Shareholding5 Jun 2026, 02:48 pm

Bakkt Opco Holdings Acquires 4.75 Cr Warrants in Transchem

AI Summary

Bakkt Opco Holdings, LLC has disclosed the acquisition of 4,75,00,000 warrants in Transchem Limited. This acquisition, made through a preferential allotment, represents 64.42% of Transchem's diluted share capital. Each warrant grants the holder the right to subscribe to one equity share of Transchem with a face value of Rs. 10, exercisable within 18 months. The total equity share capital of Transchem before and after the acquisition remains Rs. 12,24,00,000, but the diluted share capital post-acquisition is Rs. 73,74,00,000, assuming full exercise of warrants.

Key Highlights

  • Bakkt Opco Holdings acquired 4.75 crore warrants in Transchem.
  • Acquisition represents 64.42% of Transchem's diluted share capital.
  • Warrants are exercisable into equity shares within 18 months.
  • Transaction is a preferential allotment.
  • Disclosure made under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.